BBIXF (Bonus BioGroup) Common Stock: $100.89 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBIXF Bonus BioGroup Ltd BBIXF
21 GF Score
Price $0.10
! 3 Warning Signs
View Full Analysis

What is Bonus BioGroup Common Stock?

Bonus BioGroup BBIXF 21 Common Stock is $100.89 Mil as of Dec. 2025. GuruFocus rates BBIXF with a GF Score™ of 21/100. The stock has 3 warning signs investors should review.

Bonus BioGroup's quarterly common stock increased from Dec. 2024 ($99.86 Mil) to Jun. 2025 ($100.05 Mil) and increased from Jun. 2025 ($100.05 Mil) to Dec. 2025 ($100.89 Mil).

Bonus BioGroup's annual common stock increased from Dec. 2023 ($99.64 Mil) to Dec. 2024 ($99.86 Mil) and increased from Dec. 2024 ($99.86 Mil) to Dec. 2025 ($100.89 Mil).

Bonus BioGroup Common Stock Historical Data

* Premium members only.

The historical data trend for Bonus BioGroup's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonus BioGroup Common Stock Chart

Bonus BioGroup Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.62 99.02 99.64 99.86 100.89

Bonus BioGroup Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 99.64 99.79 99.86 100.05 100.89
BBIXF
21GF Score
Bonus BioGroup Ltd BBIXF
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonus BioGroup Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $100.89 Mil mean?
Bonus BioGroup (BBIXF) has a Common Stock of $100.89 Mil as of Dec. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bonus BioGroup and its competitors.
Is Bonus BioGroup's Common Stock too high?
Bonus BioGroup's current Common Stock is $100.89 Mil. Overall, Bonus BioGroup has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does Bonus BioGroup's Common Stock compare to VRTX and REGN?
Bonus BioGroup's Common Stock of $100.89 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Bonus BioGroup and its competitors. Bonus BioGroup's current Common Stock is $100.89 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bonus BioGroup stock overvalued right now?
Bonus BioGroup (BBIXF) has a current Common Stock of $100.89 Mil. The current Common Stock is $100.89 Mil. Bonus BioGroup's overall GF Score™ is 21/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Bonus BioGroup (BBIXF), the current Common Stock is $100.89 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bonus BioGroup Business Description

Other Exchanges BONS:Israel
Address Matam Advanced, Technology Park, P.O.B 15143, Haifa, ISR, 31905
Bonus BioGroup Ltd is an clinical-stage biotechnology company developing next-generation therapies for a variety of indications in the regenerative medicine field. Its products products, BonoFill and MesenCure.
21GF Score

Get the complete analysis for BBIXF

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.10
Price